S
WST icon

Seeyond’s West Pharmaceutical WST Stock Holding History

Seeyond’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$1.53M Sell
6,509
-1,242
-16% -$294K 0.15% 199
2022
Q3 		$1.91M Buy
7,751
+438
+6% +$133K 0.23% 120
2022
Q2 		$2.21M Buy
7,313
+58
+0.8% +$18.9K 0.25% 102
2022
Q1 		$2.98M Buy
7,255
+535
+8% +$209K 0.3% 77
2021
Q4 		$3.15M Sell
6,720
-692
-9% -$298K 0.29% 72
2021
Q3 		$3.15M Sell
7,412
-2,009
-21% -$847K 0.3% 65
2021
Q2 		$3.38M Buy
9,421
+42
+0.4% +$13.9K 0.32% 62
2021
Q1 		$2.64M Buy
9,379
+4,157
+80% +$1.19M 0.27% 88
2020
Q4 		$1.48M Sell
5,222
-869
-14% -$244K 0.15% 226
2020
Q3 		$1.67M Sell
6,091
-3,559
-37% -$942K 0.18% 164
2020
Q2 		$2.19M Sell
9,650
-4,420
-31% -$868K 0.25% 97
2020
Q1 		$2.14M Buy
14,070
+5,335
+61% +$821K 0.3% 75
2019
Q4 		$1.31M Buy
+8,735
New +$1.27M 0.14% 265

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Seeyond's WST Position: Q4 2022 in Review

Seeyond reduced its West Pharmaceutical (WST) stake by 16% in Q4 2022, selling an estimated $294K and leaving 6,509 shares worth $1.53M. The position accounts for 0.15% of the portfolio, ranked #199.

Seeyond first reported a position in WST in Q4 2019 and has held it in 13 quarters since. The position peaked at $3.38M in Q2 2021. 637 funds tracked by Wall St. Rank hold WST as of Q4 2022.

  • Seeyond held 6,509 shares of West Pharmaceutical worth $1.53M as of Q4 2022.
  • Seeyond sold 1,242 West Pharmaceutical shares in Q4 2022, an estimated $294K.
  • West Pharmaceutical made up 0.15% of Seeyond's portfolio in Q4 2022, its #199 holding.
  • Seeyond first reported a position in West Pharmaceutical in Q4 2019 and has held it in 13 quarters since.
  • Seeyond's West Pharmaceutical position peaked at $3.38M in Q2 2021.
  • 637 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2022.

Based on Seeyond's 13F filing for Q4 2022, filed 13 Feb 2023.